Shionogi reaches primary endpoint for ensitrelvir

Positive results in COVID-19 therapy phase 3 trials show effectiveness against five symptoms - News - PharmaTimes

Related Keywords

Vietnam ,Republic Of ,Japan ,South Korea , ,Ministry Of Health ,Drug Administration ,Devices Agency ,Food Sanitation Council ,Medical Devices Agency ,Pharmaceutical Affairs ,Shionogi ,Ensitrelvir ,Trial ,